Lista de obras - Miguel M. Coelho - Dominio Público Uruguay

Abnormal transcranial magnetic stimulation in a patient with presumed psychogenic paralysis.

artículo científico publicado en 2008

Action verbal fluency in Parkinson's patients.

artículo científico

Advanced Parkinson disease patients have impairment in prosody processing.

artículo científico publicado en 2015

Clinical and genetic characteristics of late-onset Huntington's disease

artículo científico publicado en 2018

Cognitive Impairment in Fall-Related Studies in Parkinson's Disease

artículo científico publicado en 2015

Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: Identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants ⬇️

artículo científico publicado el 28 de mayo de 2013

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

artículo científico publicado en 2011

DAT imaging in drug-induced and psychogenic parkinsonism ⬇️

artículo científico publicado el 1 de octubre de 2003

Dementia and severity of parkinsonism determines the handicap of patients in late-stage Parkinson's disease: the Barcelona-Lisbon cohort

scientific article published on 15 September 2014

Do patients with late-stage Parkinson's disease still respond to levodopa?

artículo científico publicado en 2016

Dysphagia predicts poor outcome in late-stage Parkinson's disease

artículo científico publicado en 2019

Espresso Coffee for the Treatment of Somnolence in Parkinson's Disease: Results of n-of-1 Trials

artículo científico publicado en 2016

Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).

artículo científico publicado en 2011

Facial myokymia and autonomic synkinesis responsive to carbamazepine

artículo científico publicado en 2014

Fou rire prodromique. Case report and systematic review of literature

artículo científico publicado en 2003

Has “levodopa-induced neuropathy” been reported in Parkinson's disease clinical trials?

artículo científico publicado en 2011

Health-related quality of life in multiple system atrophy

artículo científico publicado en 2006

Late-stage Parkinson disease.

artículo científico

Left hemibody myoclonus due to anomalous right vertebral artery

artículo científico publicado en 2005

Mycoplasma pneumoniae causing nervous system lesion and SIADH in the absence of pneumonia.

artículo científico publicado en 2004

Myeloradiculopathy associated to Schistosoma mansoni ⬇️

artículo científico publicado el 11 de agosto de 2011

Phenotypic variability of familial and sporadic Progranulin p.Gln257Profs*27 mutation

artículo científico publicado en 2013

Piribedil for levodopa-induced complications in Parkinson's disease

artículo científico publicado en 2007

Piribedil for symptomatic management of Parkinson's disease

artículo científico publicado en 2007

Piribedil versus levodopa in early Parkinson's disease

artículo científico publicado en 2007

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry

artículo científico publicado en 2010

Pure ataxia associated with N-methyl-D-aspartate receptor antibodies

scientific article published on 05 March 2014

Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease

artículo científico publicado en 2015

Rasagiline for levodopa-induced motor complications in Parkinson´s disease

artículo científico publicado en 2007

Red flags for multiple system atrophy

artículo científico publicado en 2008

Referral to rehabilitation in Parkinson's disease: who, when and to what end?

artículo científico publicado en 2013

STN-DBS does not change emotion recognition in Parkinson's disease

artículo científico publicado en 2014

STN-DBS does not change emotion recognition in advanced Parkinson's disease.

artículo científico publicado en 2013

Skin cancer and Parkinson's disease

scientific article published on January 2010

Skin cancers and precancerous lesions in Parkinson's disease patients.

artículo científico publicado en 2007

Spinal cord astrocytoma mimicking multifocal myelitis.

artículo científico publicado en 2014

Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.

artículo científico publicado en 2014

Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease

artículo científico publicado en 2015

Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease

artículo científico publicado en 2014

Suicidal behaviors are very rare in antiparkinsonian drug trials.

artículo científico publicado en 2015

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

artículo científico

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

artículo científico publicado en 2011

The natural history of multiple system atrophy: a prospective European cohort study

artículo científico publicado en 2013

Therapeutic interventions for daytime somnolence in Parkinson's disease

artículo científico publicado en 2007

Therapeutic interventions for disease progression in Huntington's disease

artículo científico publicado en 2009

Therapeutic interventions for disease progression in Huntington's disease

artículo científico publicado en 2007

Therapeutic interventions for sleep disorders in Parkinson's disease

artículo científico publicado en 2007

Therapeutic interventions for symptomatic treatment in Huntington's disease

artículo científico publicado en 2009

Therapeutic interventions for symptomatic treatment in Huntington's disease

artículo científico publicado en 2007

Time Perception in Mild Cognitive Impairment: Interval Length and Subjective Passage of Time

artículo científico publicado en 2016

Treatment options for non-motor symptoms in late-stage Parkinson's disease

artículo científico publicado en 2008

Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.

artículo científico publicado en 2013

What motivates Parkinson’s disease patients to enter clinical trials? ⬇️

artículo científico publicado el 28 de junio de 2011

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.

artículo científico publicado en 2009

Lista de obras de Miguel M. Coelho

Abnormal transcranial magnetic stimulation in a patient with presumed psychogenic paralysis.

Action verbal fluency in Parkinson's patients.

Advanced Parkinson disease patients have impairment in prosody processing.

Clinical and genetic characteristics of late-onset Huntington's disease

Cognitive Impairment in Fall-Related Studies in Parkinson's Disease

Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: Identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants ⬇️

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

DAT imaging in drug-induced and psychogenic parkinsonism ⬇️

Dementia and severity of parkinsonism determines the handicap of patients in late-stage Parkinson's disease: the Barcelona-Lisbon cohort

Do patients with late-stage Parkinson's disease still respond to levodopa?

Dysphagia predicts poor outcome in late-stage Parkinson's disease

Espresso Coffee for the Treatment of Somnolence in Parkinson's Disease: Results of n-of-1 Trials

Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).

Facial myokymia and autonomic synkinesis responsive to carbamazepine

Fou rire prodromique. Case report and systematic review of literature

Has “levodopa-induced neuropathy” been reported in Parkinson's disease clinical trials?

Health-related quality of life in multiple system atrophy

Late-stage Parkinson disease.

Left hemibody myoclonus due to anomalous right vertebral artery

Mycoplasma pneumoniae causing nervous system lesion and SIADH in the absence of pneumonia.

Myeloradiculopathy associated to Schistosoma mansoni ⬇️

Phenotypic variability of familial and sporadic Progranulin p.Gln257Profs*27 mutation

Piribedil for levodopa-induced complications in Parkinson's disease

Piribedil for symptomatic management of Parkinson's disease

Piribedil versus levodopa in early Parkinson's disease

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry

Pure ataxia associated with N-methyl-D-aspartate receptor antibodies

Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease

Rasagiline for levodopa-induced motor complications in Parkinson´s disease

Red flags for multiple system atrophy

Referral to rehabilitation in Parkinson's disease: who, when and to what end?

STN-DBS does not change emotion recognition in Parkinson's disease

STN-DBS does not change emotion recognition in advanced Parkinson's disease.

Skin cancer and Parkinson's disease

Skin cancers and precancerous lesions in Parkinson's disease patients.

Spinal cord astrocytoma mimicking multifocal myelitis.

Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.

Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease

Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease

Suicidal behaviors are very rare in antiparkinsonian drug trials.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

The natural history of multiple system atrophy: a prospective European cohort study

Therapeutic interventions for daytime somnolence in Parkinson's disease

Therapeutic interventions for disease progression in Huntington's disease

Therapeutic interventions for disease progression in Huntington's disease

Therapeutic interventions for sleep disorders in Parkinson's disease

Therapeutic interventions for symptomatic treatment in Huntington's disease

Therapeutic interventions for symptomatic treatment in Huntington's disease

Time Perception in Mild Cognitive Impairment: Interval Length and Subjective Passage of Time

Treatment options for non-motor symptoms in late-stage Parkinson's disease

Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.

What motivates Parkinson’s disease patients to enter clinical trials? ⬇️

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.